Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
4/11/2007
 
First Published:
5/1/2001
1.
Phase III Randomized Study of Valganciclovir to Prevent Late Cytomegalovirus Infection in Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
16 and over
NCI
FHCRC-1577.00
MSKCC-01127, NCI-H01-0072, NCT00016068
Last Modified:
7/10/2007
 
First Published:
9/16/2005
2.
Phase II Pilot Study of Targeted Oncolytic Virotherapy Comprising Bortezomib, Zidovudine, and Valganciclovir Followed By Effusion Drainage and Bevacizumab in Combination With Chemotherapy Comprising Cyclophosphamide, Doxorubicin, and Etoposide in Patients With Primary Effusion Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NCI-05-C-0203
NCI-P6330, NCT00217503
Last Modified:
5/22/2008
 
First Published:
10/6/2006
3.
Phase II Study of Phenylbutyrate and Valganciclovir in Patients With Relapsed or Refractory, Epstein-Barr Virus-Positive Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCSD-050126
ROCHE-VAL-108, NCT00387530
Last Modified:
4/1/2008
 
First Published:
10/25/2004
4.
Pilot Study of Valganciclovir in Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Completed
18 and over
NCI
MSKCC-04055
NCT00096538
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute